We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Genedata Opens Subsidiary in Tokyo

Genedata Opens Subsidiary in Tokyo

Genedata Opens Subsidiary in Tokyo

Genedata Opens Subsidiary in Tokyo

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Genedata Opens Subsidiary in Tokyo"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Swiss-based computational biology firm Genedata has established a subsidiary, Genedata KK, in Japan. The new offices in Tokyo’s Shinagawa district pave the way for a full professional services base in Japan, from which to provide local support for life sciences research with a focus on pharmaceutical research.

Japan is becoming an important global player in pharmaceutical research and development. Over the past few years, major Japanese pharmaceutical companies have expanded their research activities in the Asia region and beyond.

This has created demand for enterprise-level computational solutions for life sciences and drug discovery research. Genedata KK aims to satisfy this demand and to enable expansion of the company’s existing collaborations in Japan.

Each of Genedata’s international subsidiaries delivers computational support according to a proven collaborative framework. Genedata’s professional services points in the US, Europe and now Asia, ensure the smooth operation and evolution of its products and services.

Genedata has already attracted experienced people to the new subsidiary. The growing team, headed by Dr. Frank Staubli, brings broad knowledge and experience of the bioinformatics business in Japan. This has helped Genedata to maneuver into focused business areas, such as screening analysis and biomarker discovery as applied to toxicogenomics.

With more than five years experience providing support for drug discovery research on a global scale, Genedata has tailored its products and services for use in enterprise-wide and multi-site contexts. “We aim to help global research enterprises to bring together the best aspects of their research cultures,” explained Genedata CEO Dr. Othmar Pfannes.